50 closest statements
by meaning · ranked by similarity · 100 per pageMeaning search returns the 50 nearest statements, then applies your filters.
“Our mission is to improve the lives of individuals affected by Alzheimer’s disease by addressing both its symptoms and the disease.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-06-2764% match
“Our purpose is to operate in accordance with business considerations to generate profits (provided, however, that we may donate reasonable amounts to worthy causes, as our board of directors may determine in its discretion, even if such donations are not within the framework of business considerations).”In use 2010 – now·1 sighting·SEC Form 20-F, filed 2010-03-2662% match
“Our mission is to commercialize innovative drug candidates with novel mechanisms of action as well as intellectual property generated from our research activities for neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease.”In use 2018 – now·1 sighting·SEC Form 10-K, filed 2018-07-1661% match
“Our purpose is to engage, directly or indirectly, in any lawful business activity or occupation whatsoever; provided, however, that we may donate reasonable amounts to worthy causes, as our board of directors may determine at its discretion, even if such donations are not within the framework of business considerations.”In use 2011 – now·1 sighting·SEC Form 20-F, filed 2011-06-1660% match
RPRelx PlcCompany · Professional services · X0 Real “Our purpose is to benefit society by developing products that help researchers advance scientific knowledge; doctors and nurses improve the lives of patients; lawyers promote the rule of law and achieve justice andfair results for their clients; businesses and governments prevent fraud; consumers access financial services and get fair prices on insurance; and customers learn about markets and complete transactions.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-02-1958% match
“Our mission is to develop novel therapies by utilizing our disease-agnostic platform to address areas of high unmet medical need, initially in cancer and neurologic diseases.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-03-1058% match
“Our mission is to improve patient outcomes in the areas of neurodegenerative and oncological diseases by developing safe and effective cellular therapies that leverage the power of a patient’s immune system.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-10-0858% match
“Our mission is to design and deliver next generation immunotherapies for neurodegenerative and neuroinflammatory diseases.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-05-0157% match
“Our mission is to apply advances in neuroscience and cognitive research to increase human potential.”In use 2003 – now·1 sighting·SEC Form 10-K, filed 2003-03-3157% match
“Our mission is to develop therapies that empower the immune system to cure neurodegeneration and other diseases.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-02-2756% match
“The Company's mission is to improve the quality of life of the 70 million people in North America and the 1.5 billion people worldwide who suffer from hearing impairment and/or hearing-related issues.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-09-1456% match
“Our mission is to one day end the suffering caused by neurodegenerative diseases.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-02-2256% match
“Our mission is to identify assets to license and fund the research which we believe will be transformative to the well-being of patients and the health care industry.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-2756% match
“Our mission is to develop and commercialize innovative medicines that change the course of the disease in patients who suffer from age-related brain disorders.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1356% match
“Our purpose is to develop and commercialize HSC gene therapies that free patients from a lifetime of genetic disease.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-03-2356% match
“Our mission is to improve the lives of patients suffering from CNS diseases.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0256% match
“Our mission is to discover and develop novel therapeutics to improve the lives of patients living with debilitating CNS disorders.”In use 2025 – now·1 sighting·SEC Form S-1/A, filed 2025-10-0655% match
“Our mission is to make our products and research services available to our clients for the development of medicines and experimental therapies to address certain psychiatric health disorders and other medical needs.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-10-1355% match
“Our mission is to provide solutions to the physical conditions of the elderly during their aging process and to promote their general well-being.”In use 2021 – now·1 sighting·SEC Form 424B4, filed 2021-03-2455% match
“Our mission is to become a global leader in the treatment of rare diseases through commercializing, developing and acquiring novel rare disease products.”In use 2021 – now·1 sighting·SEC Form 424B4, filed 2021-01-1455% match
“Our mission is to slow, halt, or reverse diseases of aging.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-04-1555% match
“Our mission is to help our members achieve financial independence in order to realize their ambitions.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-02-2755% match
“Our mission is to bring off-the-shelf cellular immunotherapies with disease-transforming potential initially to patients with autoimmune diseases and cancer.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-02-2655% match
“Our mission is to benefit patients by developing and commercializing anti-cancer therapies for patients whose solid tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, with particular focus on orphan cancer indications.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-10-0754% match
“Our mission is to develop and commercialize proprietary therapeutic drug products that treat rare and orphan diseases, particularly for those diseases where no approved treatment currently exists.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-2654% match
“Our mission is to make a meaningful impact on the lives of patients with cancer and high unmet medical needs by delivering novel, PRAME-directed immunotherapies that provide tangible clinical benefits.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-03-0554% match
“Our program’s purpose is to incentivize them based on the achievement of key performance goals, and to align their interests with the interests of our stockholders.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0354% match
“Our mission is to allow seniors in need of care and support to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible.”In use 2022 – now·1 sighting·SEC Form 10-K, filed 2022-09-1354% match
“Our mission is to leverage our existing and expanding network of academic and industry leaders and investors, including venture capital and private equity, in major healthcare markets globally to identify, lead and support the growth of our subsidiaries and subsidiary candidates based on innovative research.”In use 2025 – now·1 sighting·SEC Form S-1/A, filed 2025-06-1054% match
“Our mission is to bring life-changing therapeutics to people living with rare diseases.”In use 2025 – now·1 sighting·SEC Form 10-K, filed 2025-03-1254% match
“Our mission is to be a profitable community-oriented provider of banking products and services to individuals and small businesses, including residential and commercial mortgages, consumer loans, commercial loans, and a variety of deposit instruments.”In use 2001 – now·1 sighting·SEC Form S-1/A, filed 2001-08-1054% match
“Our mission is to develop first-in-class biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy, or DMD, and other rare disorders.”In use 2020 – now·1 sighting·SEC Form 10-K, filed 2020-03-2754% match
“Our mission is to be the global leader and pioneer of this new treatment paradigm, integrating recombinant technology, gene therapy and cell therapy to address the challenges of targeting and delivering effective therapies, including to the brain for cancer and other central nervous system (“CNS”) indications.”In use 2026 – now·1 sighting·SEC Form S-1, filed 2026-08-2854% match
“The company's mission is to enhance the enterprise's efficiency and improve employees' benefit.”In use 2010 – now·1 sighting·SEC Form 10-K, filed 2010-05-2654% match
“The product’s purpose is to help human beings suffering from pain.”In use 2015 – now·1 sighting·SEC Form S-1/A, filed 2015-07-2954% match
“Our mission is to provide safe and effective treatments for mood, anxiety, depression and neurodegenerative disorders by using novel peptide-base, brain active therapeutics.”In use 2020 – now·1 sighting·SEC Form 10-K, filed 2020-04-2954% match
“Our mission is to advance drug-free neuromodulation therapies that improve patient outcomes and reduce medication burden in complex disorders, while expanding access to effective care for populations with significant unmet needs.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1954% match
“Our mission is to develop therapeutic drugs designed to treat neurodegenerative diseases, currently focusing on Parkinsonian and other movement disorders.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-08-2854% match
“Our mission is to develop, license and acquire non-invasive treatments designed to help patients affected by neurological symptoms caused by disease or trauma.”In use 2016 – now·1 sighting·SEC Form 10-K/A, filed 2016-11-0154% match
“Our mission is to create long-term stockholder value by acquiring, developing and commercializing innovative products for the treatment of a variety of human diseases that address important unmet medical needs or offer improved, cost-effective alternatives to current methods of treatment.”In use 2014 – now·1 sighting·SEC Form 10-K, filed 2014-03-1154% match
“Company’s mission is to identify subgroups of people with high costs and disability and create and implement programs and interventions that improve their health, resulting in dramatic reductions in the cost of their care.”In use 2009 – now·1 sighting·SEC Form 10-K/A, filed 2009-07-2054% match
“Our mission is to provide therapeutic relief to those suffering from debilitating rare diseases that have limited or no treatment options to help them live their best possible lives and achieve their full potential.”In use 2024 – now·1 sighting·SEC Form 20-F, filed 2024-04-3054% match
“Our purpose is to provide the energy to help people lead better lives.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-02-2454% match
“Our mission is to bring hope with life-changing therapies to patients and families that are affected by rare and niche allergic and immunological diseases.”In use 2023 – now·1 sighting·SEC Form 10-K, filed 2023-03-2254% match
“Our mission is to both extend the functional life of transplanted organ and reduce side effect of current immunosuppressive treatments such as kidney toxicity, high blood pressure, and tremor.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-1954% match
“Our mission is to help people not only live longer, but live better.”In use 2026 – now·1 sighting·SEC Form 10-K, filed 2026-03-0354% match
“Our purpose is to engage in any lawful act or activity relating to the business of chartering, rechartering or operating containerships, drybulk carriers or other vessels or any other lawful act or activity customarily conducted in conjunction with shipping, and any other lawful act or activity approved by the board of directors.”In use 2026 – now·1 sighting·SEC Form 20-F, filed 2026-02-2754% match
“Our mission is to become the leading company in precision genetic medicines by discovering, developing, manufacturing, and ultimately commercializing a new class of medicines through our proprietary base editing technology, with the goal of providing life-long cures to patients suffering from serious diseases.”In use 2020 – now·1 sighting·SEC Form 424B4, filed 2020-10-0154% match
“The Board’s mission is to further the long-term interests of the LPs.”In use 2024 – now·1 sighting·SEC Form 10-K, filed 2024-03-1153% match
“Our mission is to ‘democratize’ genetic analysis research with products that enable customers to detect and analyze complex genetic diseases by ultra-sensitive screening and monitoring of cell-free genomic targets.”In use 2015 – now·1 sighting·SEC Form S-1/A, filed 2015-03-3153% match
Showing 1–50 of 50